Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2

Conditions

Carcinoma, Non-Small-Cell Lung 13Small Cell Lung Carcinoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Neoplasms 3Lung Neoplasms 3Triple Negative Breast Neoplasms 2Thymoma 2Squamous Cell Carcinoma of Head and Neck 2Mesothelioma, Malignant 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Thyroid Neoplasms 1Ovarian Neoplasms 1Non-squamous Non-small-cell Lung Cancer 1Neoplasm Metastasis 1NSCLC 1Melanoma 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Advanced Non-squamous Non-small-cell Lung Cancer 1Advanced Non-small Cell Lung Cancer 1Adenocarcinoma 1

Interventions

Cisplatin 57Pemetrexed 46pembrolizumab 18Nivolumab 15Carboplatin 15Gemcitabine 14Cyclophosphamide 13Radiotherapy 10Drug Therapy 9atezolizumab 8Platinum 7Ipilimumab 7Doxorubicin 7durvalumab 61,2-diaminocyclohexaneplatinum II citrate 6tremelimumab 5sodium thiosulfate 5Vinorelbine 5Radiotherapy, Intensity-Modulated 5Interleukin-2 5Chemotherapy, Adjuvant 5Cerebral Decortication 5sargramostim 4fludarabine 4defactinib 4aldesleukin 4tumor necrosis factor-alpha, CNGRC fusion protein, human 3cediranib 3Photochemotherapy 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × lenvatinib × Thoracic × Clear all
NCT06318286 2025-05-25

PENINSULA

Hyogo Medical University

Phase 2 Recruiting
25 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT04287829 2024-11-05

PEMMELA

The Netherlands Cancer Institute

Phase 2 Active not recruiting
58 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡